What will you learn?

Biotech leader Glycanostics is revolutionizing cancer diagnostics and creating one-and-only opportunities for forward-thinking investors.

In our last webinar, 50 investors signed up, collectively showing interest in investing nearly €1M. Now, it’s your turn to join!

What you'll learn:

• The final design of the Giasay® Prostate diagnostic test ready for mass production in collaboration with French partner - Firalis.
• Advances in breast cancer diagnostics powered by grant funding and new test developments for other cancers.
• Key senior management hires to drive commercial milestones.

Don’t miss a chance to reserve your seat and play a part in Glycanostics international growth.

The webinar will be led by Michal Nešpor, partner at Crowdberry.